Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-06

Clinical Trial Update: Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating nitrate supplementation on cerebrovascular and cognitive function in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrate supplementation (nitrate)

Snippet

Sponsor: Penn State University | Conditions: Metabolic Syndrome | EARLY_Phase 1 | Status: COMPLETED